Hunan Haili (600731) 2020 Performance Report Review: Performance Slightly Exceeds Expectations, Opening Up Growth Space
Hunan Haili (600731): The change in the texture of the performance guidelines exceeded expectations is noteworthy
Hunan Haili (600731) three-quarter report 2020 comments: product prices rose faster than expected in the third quarter and the company's performance exceeded expectations.
Hunan Haili (600731): Performance increased year-on-year, and there are bright spots in the Guixi project
Comments on Hunan Haili (600731) Quarterly report: price rise has a good start.
Hunan Haili (600731) Annual Report Review Report: Impairment Drags Down Performance and Continued Operational Improvement
Hunan Haili (600731): Business is on the right track, room for long-term growth opens
Hunan Haili (600731): the inflection point of the three-quarter report is in line with the expectation.
Comments on Hunan Haili (600731) Quarterly report in 2019: the performance greatly exceeded expectations and paid attention to the commissioning of new production capacity such as Tishuangwei.
Hunan Haili (600731): both quantity and price rise in the future
湖南海利(600731):改革成效初显 产品梯次较好
湖南海利(600731)半年报点评:价格稳步上涨 减值拖累业绩
湖南海利(600731):产品涨价+国企改革 旧貌换新颜
湖南海利(600731)一季报预增公告点评:产品持续提价 国改红利释放 老牌农药国企迎业绩拐点
湖南海利(600731)公司年报点评:氨基甲酸酯类农药龙头 受益环保产品价格持续上涨
湖南海利(600731)年报点评:四季度净利润同比增长197.87% 费用管控成效初显
湖南海利(600731)公司调研报告:氨基甲酸酯类农药龙头 募投项目再添新活力
湖南海利(600731)深度研究:定增过会 发展空间打开
湖南海利(600731)季报点评:一季度稳定增长 期待常德项目发力
湖南海利(600731)年报点评:业绩符合预期 看好公司未来发展
No Data
No Data